New drug compound targets four hormone receptors controlling food intake and metabolism (IMAGE)
Caption
A tetra-agonist peptide (foreground helix) does the work of four separate hormones by binding to four different receptors (shown on the cell in orange/blue, violet, blue, and green). “What drives us is the idea that we can design a single drug to treat obesity and simultaneously mitigate the risk of developing a long list of health problems plaguing society,” says Krishna Kumar.
Credit
Image: Hassan @ScienceBrush
Usage Restrictions
Image may be used only with stories covering the research of Krishna Kumar, Tufts University
License
Original content